Literature DB >> 19155617

Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.

Chi-Chih Hung1, Wan-Chun Liu, Mei-Chuan Kuo, Chih-Hung Lee, Shang-Jyh Hwang, Hung-Chun Chen.   

Abstract

BACKGROUND: Skin lesion is the most frequent manifestation of adverse drug reactions. Drug-induced cutaneous hypersensitivity and drug-induced acute interstitial nephritis might share a similar mechanism involving drug-specific T cells. We thus investigated the renal outcome of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), the most severe drug-induced cutaneous hypersensitivity, and hypothesize that skin detachment in SJS/TEN might be associated with acute renal failure (ARF).
METHODS: 234 hospitalized patients were retrospectively classified into an SJS/TEN group (skin detachment) or an erythematous multiforme majus group (target-like exanthema alone).
RESULTS: Both drugs and chronic kidney disease (CKD) are associated with SJS/TEN. The SJS/TEN group was more likely to develop ARF than the erythematous multiforme majus group (18.8 vs. 4.3%, p < 0.05) despite similar initial creatinine clearance. In the ARF patients, RIFLE-F class, dialysis and long-term dialysis were 25, 15 and 5%, respectively. The offending drugs in ARF were also associated with CKD. Hyponatremia and late hypokalemia were more frequently in the SJS/TEN group (15.6 vs. 2.9%, 7.3 vs. 0.7%, respectively, p < 0.05). Sepsis, allopurinol, antibiotics, NSAIDs, CKD and hypoalbuminemia (OR: 18.8, 9.8, 10.1, 9.0, 5.3 and 3.3, respectively, p < 0.05) were the risk factors of developing ARF.
CONCLUSION: ARF, the need for dialysis, and late hypokalemia could be the consequences of SJS/TEN. Skin detachment after certain medication might implicate the associated ARF, especially in CKD patients. (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19155617     DOI: 10.1159/000195632

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  9 in total

1.  Lower-than-predicted mortality in a predominantly HIV-infected population with epidermal necrolysis regardless of HIV status: implications and challenges for interventional studies.

Authors:  Rannakoe J Lehloenya; Niita Haitembu; Wisdom Basera; Jonny Peter
Journal:  J Allergy Clin Immunol Pract       Date:  2018-11-15

Review 2.  Allopurinol, uric acid, and oxidative stress in cardiorenal disease.

Authors:  Markus Riegersperger; Adrian Covic; David Goldsmith
Journal:  Int Urol Nephrol       Date:  2011-03-10       Impact factor: 2.370

Review 3.  Defining a reference set to support methodological research in drug safety.

Authors:  Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.606

Review 4.  Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Authors:  Marianne Lerch; Carlo Mainetti; Benedetta Terziroli Beretta-Piccoli; Thomas Harr
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

5.  The influence of acute kidney injury on the outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis: The prognostic value of KDIGO staging.

Authors:  Tao Han Lee; Cheng-Chia Lee; Chau-Yee Ng; Ming-Yang Chang; Su-Wei Chang; Pei-Chun Fan; Wen-Hung Chung; Ya-Chung Tian; Yung-Chang Chen; Chih-Hsiang Chang
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

6.  Stevens-Johnson Syndrome complicated by obstructive uropathy, pneumothorax, and pneumomediastinum: a case report and literature review.

Authors:  Damian Bruce-Hickman; Xiao Jiang; Joshua Jin-Ping Thia; Amit Kansal
Journal:  Burns Trauma       Date:  2019-06-11

Review 7.  Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies.

Authors:  Christian J Wiedermann; Wolfgang Wiedermann; Michael Joannidis
Journal:  Intensive Care Med       Date:  2010-06-02       Impact factor: 17.440

Review 8.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

9.  Intravenous Immunoglobulin Combined With Corticosteroids for the Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Propensity-Matched Retrospective Study in China.

Authors:  Lu Yang; Yan-Hong Shou; Feng Li; Xiao-Hua Zhu; Yong-Sheng Yang; Jin-Hua Xu
Journal:  Front Pharmacol       Date:  2022-01-18       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.